2 unknown, 1 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Completed 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Brian Miller: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tocilizumab in Schizophrenia Tocilizumab, Normal saline - Schizophrenia, Psychotic Disorders | Phase 1 | Unknown | Brian Miller | 20 | 2016-09-01 | 2023-07-21 |
| Siltuximab in Schizophrenia Siltuximab, normal saline - Schizophrenia, Psychotic Disorders | Phase 1 / Phase 2 | Unknown | Brian Miller | 30 | 2016-05-01 | 2023-07-21 |
| An Open-Label Trial of Tocilizumab in Schizophrenia Tocilizumab - Schizophrenia | Phase 1 | Completed | Brian Miller | 8 | 2012-09-01 | 2021-07-29 |
Schizophrenia (3) · Inflammation (2) · Psychotic Disorders (2)
Saline Solution (2) · tocilizumab (2) · siltuximab (1)
United States (3)